BCL2L1 and chronic myelogenous leukemia, BCR-ABL1 positive: Furthermore, western blot analysis showed that BCL-xL expression was not significantly downregulated by any of the treatments in K562 and cytokine-treated CML stem/progenitor cells, suggesting that other mechanisms might be responsible for the TKI-induced shift in S63845 sensitivity of CML cells.